MedPath

Urinary Marker for Oxidative Stress in Human Cisplatin- Induced Renal Injury

Conditions
Kidney Failure
Registration Number
NCT00310739
Lead Sponsor
Hamamatsu University
Brief Summary

We previously reported early measurement of urinary MDA might be a useful marker for the prediction of CDDP-induced renal damage in rat. The purpose of this clinical study is to test whether the changes of human urinary excretion of MDA, and can be used as early biomarker for the prediction of development of CDDP-induced ARF.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Hospitalized patients have neck cancer
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hamamatsu University School of Medicine

🇯🇵

Hamamatsu, Shizuoka, Japan

© Copyright 2025. All Rights Reserved by MedPath